Teoxane proposal to acquire Revance Therapeutics
We are advising Teoxane on the proposed acquisition
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Paychex $4.1 billion acquisition of Paycor HCM
We are advising Paychex on the transaction
Appellate victory in liability management dispute
We secured dismissal of all claims brought against lenders that participated in a financing transaction involving Mitel
$1.15 billion refinancing and $250 million preferred offering for a software firm
We advised the lenders on the refinancing facility and the purchasers in the debt-like preferred equity investment
Olema Pharmaceuticals $150 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
J. M. Smucker cash tender offer
The offer involved five tranches of senior notes
Precigen $79 million preferred stock and warrants offering
We advised Precigen on the private placement
Personalis $50 million at-the-market offering
The shares are listed on the Nasdaq Global Market
American Savings Bank $405 million acquisition by an investor group
We advised American Savings Bank on the transactions
Barnes Group $750 million senior secured notes offering
The high-yield notes are part of the financing for an Apollo-led investor group’s acquisition of Barnes